These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32626956)

  • 1. miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
    Pan Y; Sun Y; Liu Z; Zhang C
    Mol Med Rep; 2020 Aug; 22(2):1594-1604. PubMed ID: 32626956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells.
    Wang JY; Wang X; Wang XJ; Zheng BZ; Wang Y; Wang X; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7492-7499. PubMed ID: 30468498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
    Tan X; Jiang L; Wu X; Feng W; Lin Q
    Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/β‑catenin pathway and feedback regulation by c‑myc.
    Xiong J; Xing S; Dong Z; Niu L; Xu Q; Liu P; Yang P
    Oncol Rep; 2020 Feb; 43(2):395-404. PubMed ID: 31894338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.
    Chen QY; Jiao DM; Wang LF; Wang L; Hu HZ; Song J; Yan J; Wu LJ; Shi JG
    Mol Biosyst; 2015 Mar; 11(3):859-68. PubMed ID: 25578635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
    Xu X; Zhang X; Zhang Y; Wang Z
    Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
    Liu L; Wang R; Zhang Z; Wang X
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N; Feng T; Liu X; Liu Q
    Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.
    Lei Z; Shi H; Li W; Yu D; Shen F; Yu X; Lu D; Sun C; Liao K
    Mol Med Rep; 2018 Jan; 17(1):1742-1752. PubMed ID: 29138830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
    Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
    Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577.
    Zhang WT; Zhang JJ; Shao Q; Wang YK; Jia JP; Qian B; Tian XW; Yan WJ
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34821374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.
    Wang T; Liu X; Tian Q; Liang T; Chang P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):637-644. PubMed ID: 29461591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
    Wang L; Zhao Y; Wu Q; Guan Y; Wu X
    Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
    Li K; Yuan C
    Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑671‑5p inhibits cell proliferation, migration and invasion in non‑small cell lung cancer by targeting MFAP3L.
    Ye J; Luo W; Luo L; Zhai L; Huang P
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34841435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.
    Liang H; Wang C; Gao K; Li J; Jia R
    Mol Med Rep; 2019 Jul; 20(1):151-161. PubMed ID: 31115507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
    Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
    Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.